Martin Gauthier

Cahors, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Treatment Modalities and the Impact of Granulocyte Colony-Stimulating Factor in AML Patients Treated With Venetoclax and Azacitidine: A DATAML Registry Study.

Treatment Modalities and the Impact of Granulocyte Colony-Stimulating Factor in AML Patients Treated With Venetoclax and Azacitidine: A DATAML Registry Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 05, 2026

Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma.

Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 26, 2025

Levofloxacin to Prevent Bacterial Infection in Patients With Acute Myeloid Leukemia Treated by Venetoclax and Azacitidine: A Toulouse-Bordeaux DATAML Registry Study.

Levofloxacin to Prevent Bacterial Infection in Patients With Acute Myeloid Leukemia Treated by Venetoclax and Azacitidine: A Toulouse-Bordeaux DATAML Registry Study.

Journal: Open forum infectious diseases

Published: November 05, 2024

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Journal: American journal of hematology

Published: October 15, 2024

Benefit of phlebotomy and low-dose aspirin in the prevention of vascular events in patients with EPOR primary familial polycythemia on the island of New Caledonia.

Benefit of phlebotomy and low-dose aspirin in the prevention of vascular events in patients with EPOR primary familial polycythemia on the island of New Caledonia.

Journal: Haematologica

Published: December 08, 2023

Vacuolated lymphocytes as initial presentation of angioimmunoblastic T-cell lymphoma.

Vacuolated lymphocytes as initial presentation of angioimmunoblastic T-cell lymphoma.

Journal: British journal of haematology

Published: August 24, 2023

A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.

A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.

Journal: Cytotherapy

Published: November 18, 2022

Looking for the truth: an IGH-MYC+ lymphoid neoplasm with immature B-cell phenotype (CD34 positivity) successfully treated with Burkitt lymphoma protocol.

Looking for the truth: an IGH-MYC+ lymphoid neoplasm with immature B-cell phenotype (CD34 positivity) successfully treated with Burkitt lymphoma protocol.

Journal: Annales de biologie clinique

Published: June 29, 2022

"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies.

"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies.

Journal: Hematological oncology

Published: March 05, 2022

Nephropathy associated with monoclonal immunoglobulins: From clonal expansion B to renal toxicity of pathological immunoglobulins

Nephropathy associated with monoclonal immunoglobulins: From clonal expansion B to renal toxicity of pathological immunoglobulins

Journal: Nephrologie & therapeutique

Published: March 02, 2022

Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system.

Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system.

Journal: American journal of hematology

Published: February 14, 2022

Look beyond the plasma cells in immunocompromised patients.

Look beyond the plasma cells in immunocompromised patients.

Journal: International journal of laboratory hematology

Published: November 18, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026